Insights from ASCO 2025, including anticipated presentations, key takeaways, and how new research in prostate cancer may impact patients.
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.will be held May 30 to June 3 in Chicago, Illinois.
As the world’s leading forum for cutting-edge research and collaboration, this event brings together top minds to drive innovation and shape the future oftreatment. Attendees can expect over 200 dynamic sessions designed to deepen knowledge and spark discovery, along with state-of-the-art science that keeps them on the leading edge of treatment advancements. Anticipated presentations include phase 1 results from themultimodal AI to predict benefit from 2nd-generation androgen receptor pathway inhibitors Professor; Clinical Director, Department of Medicine and Hematology/Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, Washington "The prostate cancer field is moving so rapidly forward. So, there is a lot of interest and excitement in how we can learn from these data sets and potentially apply some of the data to our patient care.”Dr Grivas looks forward to the 2025 ASCO Annual Meeting and its valuable presentations on clinical trials, real-world data, and educational content. He highlights key sessions in prostate cancer, including updates on the AMPLITUDE trial and the IRONMAN registry, as well as discussions on genomic testing and emerging therapies such as bispecific antibodies and radioligands. He also emphasizes the importance of translating this data into clinical practice and encourages broad participation in the meeting.Any views expressed above are the author's own and do not necessarily reflect the views of WebMD/Medscape or its affiliates.Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see ourPatient Simulation: A 68-Year-Old Man With Prostate Cancer, Fatigue, and Worsening Pelvic Pain
Malignant Prostate Neoplasm Prostate Cancer Cancer Of The Prostate Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Prostatic Medical Conferences Professional Societies Genomics Genomic Medicine Mdangle Fellowship Fellows Residency Residents Medical Innovations Innovations In Medicine Innovation Washington Artificial Intelligence Deep Learning AI NPL
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ballon d'Or 2025 Odds: Who Will Win the 2025 Ballon d'Or?Chris Vasile breaks down the latest Ballon d'Or odds as we reach the climax of the 2024-25 season.
Read more »
Razr Ultra 2025 vs Razr Plus 2025 vs Razr 2025, which should you buy?There's a new flagship flip phone in town, but should you buy the Razr Ultra 2025? Do the Razr Plus 2025 or Razr 2025 offer a good enough experience at a lower price? Let's take a look.
Read more »
See which Netflix shows are canceled and renewed for the 2025-2026 seasonNetflix has already renewed a slew of shows for 2025 and 2025
Read more »
Here’s When the 2025 CMA Awards Will Be HeldThe 2025 CMA Awards announced 2025 date and some changes.
Read more »
Conference MDAngle: ASCO 2025Insights from ASCO 2025, including anticipated presentations, key takeaways, and how emerging research in advanced NSCLC may impact patient care.
Read more »
Conference MDAngle: ASCO 2025Insights from ASCO 2025, including anticipated presentations, key takeaways, and how emerging research in endometrial and related cancers may impact patient care.
Read more »